Morgan Stanley Upgrades Pfizer (PFE) to Overweight
Tweet
Share
E-mailGet Alerts PFE Hot Sheet
Price: $26.44 +0.69%
Rating Summary:
13 Buy, 20 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 10 | New: 13
Rating Summary:
13 Buy, 20 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 10 | New: 13
Join SI Premium – FREE
Morgan Stanley upgraded Pfizer (NYSE: PFE) from Equalweight to Overweight with a price target of $38.00.
For an analyst ratings summary and ratings history on Pfizer click here. For more ratings news on Pfizer click here.
Shares of Pfizer closed at $31.84 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercore ISI Upgrades First Solar (FSLR) to Outperform
- Canaccord Genuity Upgrades Gatos Silver (GATO) to Buy
- Roth/MKM Upgrades Albertsons Companies Inc. (ACI) to Buy, 'Fundamental Floor and Improved Deal Likelihood'
Create E-mail Alert Related Categories
Hot Upgrades, UpgradesRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
